Nephros annual debt-to-assets ratio
2010
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Nephros's debt-to-assets ratio was 0.08 for fiscal 2025.
View full Nephros company overview| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.08 | −0.05 | −38.09% |
| 2024 | 2024-12-31 | 0.13 | −0.03 | −18.69% |
| 2023 | 2023-12-31 | 0.15 | 0.06 | +55.91% |
| 2022 | 2022-12-31 | 0.10 | 0.04 | +71.80% |
| 2021 | 2021-12-31 | 0.06 | −0.03 | −36.48% |
| 2020 | 2020-12-31 | 0.09 | −0.08 | −46.43% |
| 2019 | 2019-12-31 | 0.17 | 0.07 | +72.75% |
| 2018 | 2018-12-31 | 0.10 | −0.09 | −48.65% |
| 2017 | 2017-12-31 | 0.19 | −0.12 | −38.82% |
| 2016 | 2016-12-31 | 0.31 | — | — |
| 2010 | 2010-12-31 | 0.31 | — | — |
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.06 | −0.05 | −45.45% |
| Q1 2026 | 2026-03-31 | 0.07 | −0.04 | −37.71% |
| Q4 2025 | 2025-12-31 | 0.08 | −0.05 | −38.09% |
| Q3 2025 | 2025-09-30 | 0.09 | −0.06 | −39.36% |
| Q2 2025 | 2025-06-30 | 0.10 | −0.04 | −28.79% |
| Q1 2025 | 2025-03-31 | 0.11 | −0.04 | −24.74% |
| Q4 2024 | 2024-12-31 | 0.13 | −0.03 | −18.69% |
| Q3 2024 | 2024-09-30 | 0.14 | 0.07 | +101.10% |
| Q2 2024 | 2024-06-30 | 0.14 | 0.06 | +72.50% |
| Q1 2024 | 2024-03-31 | 0.15 | 0.06 | +75.70% |
| Q4 2023 | 2023-12-31 | 0.15 | 0.06 | +55.91% |
| Q3 2023 | 2023-09-30 | 0.07 | 0.02 | +41.81% |
| Q2 2023 | 2023-06-30 | 0.08 | 0.02 | +41.33% |
| Q1 2023 | 2023-03-31 | 0.09 | 0.07 | +377.62% |
| Q4 2022 | 2022-12-31 | 0.10 | 0.04 | +71.80% |
| Q3 2022 | 2022-09-30 | 0.05 | −0.02 | −29.37% |
| Q2 2022 | 2022-06-30 | 0.06 | −0.02 | −25.98% |
| Q1 2022 | 2022-03-31 | 0.02 | −0.07 | −79.54% |
| Q4 2021 | 2021-12-31 | 0.06 | −0.03 | −36.48% |
| Q3 2021 | 2021-09-30 | 0.07 | −0.05 | −40.40% |
| Q2 2021 | 2021-06-30 | 0.08 | −0.04 | −32.10% |
| Q1 2021 | 2021-03-31 | 0.09 | −0.03 | −22.86% |
| Q4 2020 | 2020-12-31 | 0.09 | −0.08 | −46.43% |
| Q3 2020 | 2020-09-30 | 0.12 | −0.06 | −33.72% |
| Q2 2020 | 2020-06-30 | 0.12 | −0.07 | −35.95% |
| Q1 2020 | 2020-03-31 | 0.11 | −0.04 | −27.60% |
| Q4 2019 | 2019-12-31 | 0.17 | 0.07 | +72.75% |
| Q3 2019 | 2019-09-30 | 0.18 | 0.06 | +56.05% |
| Q2 2019 | 2019-06-30 | 0.18 | 0.02 | +9.09% |
| Q1 2019 | 2019-03-31 | 0.16 | — | — |
| Q4 2018 | 2018-12-31 | 0.10 | −0.09 | −48.65% |
| Q3 2018 | 2018-09-30 | 0.12 | −0.21 | −64.56% |
| Q2 2018 | 2018-06-30 | 0.17 | −0.15 | −47.05% |
| Q4 2017 | 2017-12-31 | 0.19 | −0.12 | −38.82% |
| Q3 2017 | 2017-09-30 | 0.33 | 0.06 | +20.73% |
| Q2 2017 | 2017-06-30 | 0.31 | 0.12 | +58.57% |
| Q1 2017 | 2017-03-31 | 0.26 | — | — |
| Q4 2016 | 2016-12-31 | 0.31 | — | — |
| Q3 2016 | 2016-09-30 | 0.27 | — | — |
| Q2 2016 | 2016-06-30 | 0.20 | — | — |
| Q4 2010 | 2010-12-31 | 0.31 | — | — |
Over the last five fiscal years, Nephros's debt-to-assets ratio decreased from 0.09 to 0.08, a change of −0.01. The latest reported quarter, Q2 2026, shows 0.06.
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nephros source filings ↗